R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
R3	Has_value Arg1:T7 Arg2:T8	
R4	Has_multiplier Arg1:T5 Arg2:T9	
R5	Has_qualifier Arg1:T10 Arg2:T11	
R6	Has_temporal Arg1:T10 Arg2:T12	
R7	Has_qualifier Arg1:T14 Arg2:T15	
R8	AND Arg1:T14 Arg2:T13	
R9	Has_value Arg1:T16 Arg2:T17	
R10	Has_value Arg1:T18 Arg2:T19	
R11	Has_qualifier Arg1:T20 Arg2:T21	
R12	Has_temporal Arg1:T20 Arg2:T22	
R13	Has_value Arg1:T26 Arg2:T27	
R14	Has_value Arg1:T28 Arg2:T29	
T1	Condition 13 43	idiopathic Parkinson's disease
T2	Qualifier 62 69	treated
T3	Measurement 71 89	motor fluctuations
T4	Value 90 118	<20% of subject's awake time
T5	Observation 213 228	Sexually active
T6	Person 252 257	males
T7	Person 276 279	age
T8	Value 259 272	40 - 64 years
T9	Multiplier 235 250	=1 attempt/week
T10	Condition 336 356	erectile dysfunction
T11	Qualifier 327 335	moderate
T12	Temporal 429 451	for more than 6 months
T13	Drug 497 506	tadalafil
T14	Condition 485 493	response
T15	Qualifier 474 484	incomplete
T16	Measurement 539 570	IIEF-5 drug-free baseline score
T17	Value 579 592	= 10 but = 16
T18	Measurement 601 638	IIEF-5 tadalafil-alone baseline score
T19	Value 647 651	= 18
T20	Observation 673 698	heterosexual relationship
T21	Qualifier 666 672	stable
T22	Temporal 703 720	at least 6 months
T23	Condition 767 787	erectile dysfunction
T24	Procedure 753 762	treatment
T25	Post-eligibility 727 787	Subject motivated to seek treatment for erectile dysfunction
T26	Measurement 805 835	total serum testosterone level
T27	Value 836 847	= 300 ng/dL
T28	Measurement 882 908	Hoehn and Yahr Scale score
T29	Value 912 917	1 - 3
T30	Informed_consent 919 980	Patient able to consent and comply with protocol requirements
